Method for detecting rhabdomyosarcoma using sample derived from body fluid
US8975021B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 7, 2011 |
| Grant date | Mar 10, 2015 |
| Priority date | — |
| Expiry date | Jun 12, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/178
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides a method for detecting rhabdomyosarcoma comprising evaluating expression of at least one kind of miRNA selected from the group consisting of hsa-miR-1, hsa-miR-133a, hsa-miR-133b, and hsa-miR-206 in a sample derived from body fluid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.